Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease multiple myeloma
Symptom C0021311|infections
Sentences 8
PubMedID- 23355264 Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens.
PubMedID- 26489539 Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization.
PubMedID- 25304609 Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies.
PubMedID- 20691039 As a gammopathy, multiple myeloma generally presents with recurrent infections secondary to humoral immune deficiencies, or with bone pain as a result of osteolytic lesions.
PubMedID- 25343940 Drug-induced modulation of t lymphocytes as a potential mechanism of susceptibility to infections in patients with multiple myeloma during bortezomib therapy.
PubMedID- 21988413 Results: necrotizing soft tissue infections are rare in patients with multiple myeloma.
PubMedID- 26033514 Immune dysfunction is an important feature of multiple myeloma (mm) leading to infections, enhancement of tumour growth and resistance to chemotherapy.
PubMedID- 26105211 Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy.

Page: 1